Prospective Associations and Population Impact of Sweet Beverage Intake and Type 2 Diabetes, and Effects of Substitutions with Alternative Beverages
Overview
Authors
Affiliations
Aims/hypothesis: This study aimed to evaluate the association of types of sugar-sweetened beverages (SSB) (soft drinks, sweetened-milk beverages, sweetened tea/coffee), artificially sweetened beverages (ASB) and fruit juice with incident type 2 diabetes and determine the effects of substituting non-SSB for SSB and the population-attributable fraction of type 2 diabetes due to total sweet beverages.
Methods: Beverage consumption of 25,639 UK-resident adults without diabetes at baseline (1993-1997) in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study was assessed using 7-day food diaries. During 10.8 years of follow-up 847 incident type 2 diabetes cases were verified.
Results: In adjusted Cox regression analyses there were positive associations (HR [95% CI] per serving/day]) for soft drinks 1.21 (1.05, 1.39), sweetened-milk beverages 1.22 (1.05, 1.43) and ASB 1.22 (1.11, 1.33), but not for sweetened tea/coffee 0.98 (0.94, 1.02) or fruit juice 1.01 (0.88, 1.15). Further adjustment for adiposity attenuated the association of ASB, HR 1.06 (0.93, 1.20). There was a positive dose-response relationship with total sweet beverages: HR per 5% energy 1.18 (1.11, 1.26). Substituting ASB for any SSB did not reduce the incidence in analyses accounting for energy intake and adiposity. Substituting one serving/day of water or unsweetened tea/coffee for soft drinks and for sweetened-milk beverages reduced the incidence by 14%-25%. If sweet beverage consumers reduced intake to below 2% energy, 15% of incident diabetes might be prevented.
Conclusions/interpretation: The consumption of soft drinks, sweetened-milk beverages and energy from total sweet beverages was associated with higher type 2 diabetes risk independently of adiposity. Water or unsweetened tea/coffee appear to be suitable alternatives to SSB for diabetes prevention. These findings support the implementation of population-based interventions to reduce SSB consumption and increase the consumption of suitable alternatives.
Smyth A, Hankey G, Damasceno A, Iversen H, Oveisgharan S, Alhussain F J Stroke. 2024; 26(3):391-402.
PMID: 39326863 PMC: 11471353. DOI: 10.5853/jos.2024.01543.
Sun T, Yang J, Lei F, Huang X, Liu W, Zhang X Cardiovasc Diabetol. 2024; 23(1):233.
PMID: 38965574 PMC: 11225337. DOI: 10.1186/s12933-024-02333-9.
Ding P, Yue W, Wang X, Zhang Y, Liu Y, Guo X J Diabetes Metab Disord. 2024; 23(1):1113-1123.
PMID: 38932853 PMC: 11196440. DOI: 10.1007/s40200-024-01396-5.
Pourmoradian S, Kalantari N, Eini-Zinab H, Ostadrahimi A, Tabrizi J, Faramarzi E Health Promot Perspect. 2024; 14(1):53-60.
PMID: 38623351 PMC: 11016142. DOI: 10.34172/hpp.42452.
Cha E, Choi Y, Bancks M, Faulkner M, Dunbar S, Umpierrez G BMJ Open Diabetes Res Care. 2024; 12(2).
PMID: 38453235 PMC: 10921527. DOI: 10.1136/bmjdrc-2023-003800.